Cushman & Wakefield Further Strengthens it's UK Life Sciences Capabilities with Two Key Appointments
31/01/2024
The firm has appointed Chloe Garth, Partner, to lead Life Sciences Valuation & Advisory and provide valuation advice to investors, developers and lenders operating across the UK. Garth has considerable experience in the Life Sciences sector, and across the wider London & South East market, a region that includes the Golden Triangle, one of the world’s leading life sciences and biotechnology clusters, with its points at Oxford, Cambridge, and London. Garth joined Cushman & Wakefield from JLL last year.
Tom Nuttall, Head of UK Valuation & Advisory at Cushman & Wakefield, said: “We have a strong track record in the sector and valued more than 30 million sq ft of Life Sciences real estate across the UK last year. Chloe has the specialist knowledge and experience for this new position leading our advice to clients, supporting them in making informed decisions and continuing our growth in this expanding sector.”
Chloe Garth, UK Life Sciences Valuation & Advisory lead at Cushman & Wakefield, said: “Life Sciences is a maturing market in the UK and the construction of more purpose-built stock, both in established and emerging clusters, is starting to make a dent in the supply-demand imbalance. I look forward to leading Cushman & Wakefield’s valuation activity in this fascinating sector.”
Cushman & Wakefield has also appointed Rory MacGregor to lead its Capital Markets activity in the Life Sciences sector. MacGregor was previously a Partner within the firm’s UK Life Sciences advisory team and has been advising clients in the sector since 2019. In his new role, MacGregor will work across EMEA, with a strong focus on the UK, specifically the Golden Triangle, in which Cushman & Wakefield has advised on several notable investment transactions.
These include working on behalf of the London Borough of Sutton to secure Aviva and Socius as funding and development partners for a 1m-sq-ft commercial life sciences campus at the London Cancer Hub, as well as advising GSK on their R&D campus at Stevenage, where Cushman & Wakefield brought in UBS Asset Management and Reef Group to realise the vision for a new biotech ecosystem on the remaining 33 acres of land.
Rory MacGregor, UK Life Sciences Capital Markets lead, Cushman & Wakefield, added: “I’m incredibly excited to lead and build upon Cushman & Wakefield’s strong Life Sciences Capital Markets offering. As a team, we have already been at the forefront of the sector having worked on market leading transactions such as the land disposal at The London Cancer Hub in 2023, GSK’s R&D Headquarters in 2022, and The Oxford Science Park in 2021.”
Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In 2023, the firm reported revenue of $9.5 billion across its core services of property, facilities and project management, leasing, capital markets, and valuation and other services. It also receives numerous industry and business accolades for its award-winning culture and commitment to Diversity, Equity and Inclusion (DEI), sustainability and more. For additional information, visit www.cushmanwakefield.com.
What's new
Cushman & Wakefield Advises On The Sale of The Holiday Inn Express Southampton
Cushman & Wakefield’s UK Hospitality team has advised Brightbay Real Estate Partners (BBREP) on the sale of the Holiday Inn Express Southampton, M27 J7 to UK-based family office Hunton Hotels.
21/12/2023
Cushman & Wakefield Welcomes Senior Hire To UK Capital Markets Team
Global real estate services firm, Cushman & Wakefield, has appointed James Yates as a Partner to its UK Capital Markets team.
24/11/2023
MyCity 2023
This autumn, we’re excited to unpack our vision for the future of six UK cities: London, Birmingham, Bristol, Manchester, Leeds and Edinburgh. We consider how well placed each is to manage the challenges and opportunities ahead.
Insights
Research
Research
Build To Rent Quarterly Report
Research
Elderly Care Real Estate Scorecard
MarketBeat
Hospitality Market Trends & Data
The latest hospitality market insights are based on the in-depth analysis of our extensive data sets, surveys of investors, operators and lenders and up-to-date market intelligence from our team members on-the-ground in all major European markets.